#Fed Rate Cut Ahead

Helius Medical Technologies (Nasdaq: HSDT) announced over $500 million in funding to launch a treasury strategy based on Solana, in partnership with Pantera Capital and Summer Capital. This initiative aims to create a leading Solana treasury instrument while opening capital markets to further accelerate Solana's growth.
The re-subscribed private investment in public equity (PIPE) was valued at $6.881 per share, with attached warrants exercisable at $10.134. Helius intends to use the proceeds to acquire SOL as its primary reserve asset, leveraging its staking yield and broader defi opportunities.
"A productive treasury company that supports the most affordable, fast, and accessible network in the industry can significantly increase access for institutional and retail investors to the Solana ecosystem and help its global adoption," said Dan Morehead, founder of Pantera Capital.
A broad coalition of institutional and cryptocurrency investors supported the deal, including Big Brain Holdings, Arrington Capital, Animoca Brands, FalconX, Borderless, Hashkey Capital, and Republic Digital.
Solana has strong network metrics, with 3.7 million active wallets daily, over 23 billion transactions since the beginning of the year, and a throughput of more than 3,500 transactions per second.